The new API plant is set up to meet all domestic and international regulatory standards and will manufacture niche molecules that have a global requirement
The approval of this important test marks the 14th IVD to receive clearance by the CDSCO, and strengthens the company’s foundation for future growth
It tests for the presence or absence of ribonucleic acid (RNA) of Dengue (Type 1, 2 4) in serum or plasma from patients suspected of dengue viral infection.
Subscribe To Our Newsletter & Stay Updated
